Clinical Trial Update: Zanubrutinib Combined With G-CVP in Previously Untreated FL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on zanubrutinib combined with G-CVP for previously untreated follicular lymphoma; recruitment is ongoing in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• G-CVP
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Follicular Lymphoma ( FL) | Phase 2 | Status: RECRUITING